A
ACRO Biomedical Co Ltd
OTC:ACBM
ACRO Biomedical Co Ltd
OTC:ACBM
Price:
0.0222
USD
Market Closed
Market Cap:
$1.3m
Relative Value
The Relative Value of one ACBM stock under the Base Case scenario is 0.0104 USD. Compared to the current market price of 0.0222 USD, ACRO Biomedical Co Ltd is Overvalued by 53%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ACBM
Relative Value
Base Case
0.0104
USD
Overvaluation 53%
A
Multiples Across Competitors
ACBM Competitors Multiples
ACRO Biomedical Co Ltd Competitors
ACRO Biomedical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
A
|
ACRO Biomedical Co Ltd
OTC:ACBM
|
1.3m USD | 0 | -13.2 | -10.7 | -10.7 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
116.2B USD | 0.3 | 26.8 | 18.8 | 21.1 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.4B USD | 0.2 | 42.1 | 14.8 | 18.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
68.6B USD | 0.2 | 42.3 | 14.8 | 18.8 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
51.7B USD | 0.2 | 31.1 | 15 | 19.5 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.7B AUD | 2.7 | 33.8 | 25.1 | 25.1 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.8B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
62B CNY | 1.4 | 16.8 | 12.9 | 12.9 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.7B USD | 0.7 | 21.8 | 10.8 | 15.2 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
64.9B HKD | 0.1 | 8.4 | 1.5 | 1.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
